Thursday, 28 February 2019

BAT CEO says supports FDA on youth vaping, challenges idea there is basis for menthol ban

British American Tobacco does not believe there is scientific evidence to support potential U.S. restrictions on menthol cigarettes and believes such restrictions would have no impact on smoking rates, its chief executive told Reuters on Thursday.


Novavax shares plunge 65 percent as respiratory vaccine fails in late-stage trial

Novavax Inc shares crashed 65 percent on Thursday after data showed its vaccine failed to prevent RSV disease, a leading cause of respiratory infections in infants, missing the main goal of a late-stage study.


FDA flags concerns at Akorn's Amityville plant

Akorn Inc said on Thursday the U.S. Food and Drug Administration pointed out certain concerns at its manufacturing plant in Amityville, New York, that included lack of records on the maintenance and cleaning of equipment.